Menu
W 27: Is the World’s Third Largest Pharmaceutical Market Ready for Patient-Centric Clinical Trials?
Poster Presenter
- Associate Director & Head, Clinical Planning & Analytics Asia Pacific
- IQVIA
Singapore
Saumya Nayak
Objectives
Method
In total, from 28th Sep to 16th Nov 2015, 121 patient groups were contacted in China. The groups were sent an electronic survey & followed-up by telephone or instant messages for survey completion. Of the 40 respondents, data from 35 groups interested in clinical trials were analyzed qualitatively.